Takeda Pharmaceutical (TAK) Inventory Average: 2019-2025

Historic Inventory Average for Takeda Pharmaceutical (TAK) over the last 7 years, with Mar 2025 value amounting to $8.2 billion.

  • Takeda Pharmaceutical's Inventory Average rose 3.34% to $8.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $8.1 billion, marking a year-over-year increase of 3.34%. This contributed to the annual value of $8.2 billion for FY2025, which is 4.40% up from last year.
  • Per Takeda Pharmaceutical's latest filing, its Inventory Average stood at $8.2 billion for FY2025, which was up 4.40% from $7.8 billion recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Inventory Average ranged from a high of $8.2 billion in FY2025 and a low of $7.1 billion during FY2021.
  • In the last 3 years, Takeda Pharmaceutical's Inventory Average had a median value of $7.8 billion in 2024 and averaged $7.8 billion.
  • Its Inventory Average has fluctuated over the past 5 years, first fell by 7.76% in 2021, then increased by 5.30% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Inventory Average (Yearly) stood at $7.1 billion in 2021, then increased by 4.33% to $7.4 billion in 2022, then grew by 1.30% to $7.5 billion in 2023, then climbed by 5.30% to $7.8 billion in 2024, then rose by 4.40% to $8.2 billion in 2025.